CCR5 and HIV-1 infection: For example, Xu et al. recently reported successful transplantation and engraftment of allogeneic HSCs with CCR5 disruption by a CRISPR/Cas9 system in a patient with HIV-1 infection and acute lymphoblastic leukemia, which demonstrated safety but no therapeutic efficacy for HIV-1 was observed [8].